Colgate-Palmolive (NYSE: CL) reported Q2 EPS of $0.99, $0.04 better than the analyst estimate of $0.95. Revenue for the quarter came in at $5.36 billion versus the consensus estimate of $5.36 billion.

Full Year 2026 Guidance
Based on current spot rates:

• The Company still expects net sales to be up 2% to 6%, including a low-single-digit positive impact from foreign exchange.
• The Company still expects organic sales growth to be 1% to 4%. This includes the impact from our exit from the private label pet food business.
• On a GAAP basis, the Company now expects gross profit margin to be roughly flat (versus down previously) and still expects advertising to be up on both a dollar basis and as a percentage of net sales and double-digit earnings per share growth.
• On a non-GAAP (Base Business) basis, the Company now expects gross profit margin to be roughly flat (versus down previously) and still expects advertising to be up on both a dollar basis and as a percentage of net sales; it also now expects mid-single-digit earnings per share growth (versus low- to mid-single-digit growth previously).

For earnings history and earnings-related data on Colgate-Palmolive (CL) click here.